FDA Inspection
Tubilux Pharma SpaTubilux Pharma Spa – FDA Inspection, Jun 14, 2024
Record Details
This FDA Inspection record concerns Tubilux Pharma Spa, with an inspection on June 14, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 31665e2a-33dc-471b-803b-4709debae59b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1263915
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Tubilux Pharma Spa
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 10, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 6, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 9, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tubilux Pharma Spa
- FDA Inspection 1115090 - 2019-12-10
- FDA Inspection 1047718 - 2018-04-06
- FDA Inspection 998341 - 2016-12-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.